XML 107 R93.htm IDEA: XBRL DOCUMENT
v3.22.0.1

Payroll costs, share based payments and management incentive schemes - Director and Senior Management Share Awards Narrative (Details) € in Millions | 1 Months Ended | 12 Months Ended |  |  |  |  |  |  |  |  |
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Feb. 28, 2021 shares | Jan. 31, 2021 shares | Sep. 30, 2020 shares | Feb. 29, 2020 shares | Jan. 31, 2020 shares | Sep. 30, 2019 shares | Jan. 31, 2019 shares | Dec. 31, 2021 EUR (€) shares | Dec. 31, 2020 EUR (€) | Dec. 31, 2019 EUR (€) | Dec. 31, 2021 shares $ / shares | Feb. 01, 2021 $ / shares | Jan. 30, 2021 $ / shares | Jan. 01, 2021 $ / shares | Dec. 31, 2020 shares $ / shares | Sep. 01, 2020 $ / shares | Aug. 01, 2020 $ / shares | Feb. 01, 2020 $ / shares | Jan. 01, 2020 $ / shares
EBITDA |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  | 3 years |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  | 3 years |  |  |  |  |  |  |  |  |  |  |
Share price performance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  | 3 years |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  | 3 years |  |  |  |  |  |  |  |  |  |  |
Cumulative net sales |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  | 3 years |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  | 3 years |  |  |  |  |  |  |  |  |  |  |
Ordinary shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share price (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 24.50 |  | $ 25.29 |  | $ 21.04 |  | $ 25.50 |  |
Management Award 2018 | EBITDA |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  | 4 years |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  | 4 years |  |  |  |  |  |  |  |  |  |  |
Management Award 2018 | Share price performance |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  | 3 years |  | 2 years |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  | 3 years |  | 2 years |  |  |  |  |  |  |  |  |
Management Award 2018 | Share price performance | Bottom of range |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  | 2 years |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  | 2 years |  |  |  |  |  |  |  |  |  |  |
Management Award 2018 | Share price performance | Top of range |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |
Vesting period |  |  |  |  |  |  |  | 5 years |  |  |  |  |  |  |  |  |  |  |
Restricted Shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of equity instruments outstanding in share-based payment arrangement (in shares) |  |  |  |  |  |  |  |  |  |  | 2,016,855 |  |  |  | 3,178,400 |  |  |  |
New awards granted in the period |  |  |  |  |  |  |  | 820,202 |  |  |  |  |  |  |  |  |  |  |
Number of equity instruments exercised (in shares) |  |  |  |  |  |  |  | 1,861,826 |  |  |  |  |  |  |  |  |  |  |
Restricted Shares | Key management personnel |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Expense from share-based payment transactions with employees | € |  |  |  |  |  |  |  | € 4.3 | € 8.3 | € 14.0 |  |  |  |  |  |  |  |  |
Restricted Shares | Management Award 2017 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of equity instruments exercised (in shares) | 451,719 | 368,154 |  |  |  |  | 85,315 |  |  |  |  |  |  |  |  |  |  |  |
Reclassification of awards for settlement of tax liabilities | 180,268 | 150,926 |  |  |  |  | 33,383 |  |  |  |  |  |  |  |  |  |  |  |
Share price (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  | $ 25.89 |  | $ 25.42 |  |  |  |  |
Restricted Shares | Management Award 2017 | Ordinary shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of equity instruments exercised (in shares) | 271,451 | 217,228 |  |  |  |  | 51,932 |  |  |  |  |  |  |  |  |  |  |  |
Restricted Shares | Management Award 2016 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of equity instruments exercised (in shares) |  | 1,041,953 |  | 1,626,006 | 284,555 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Reclassification of awards for settlement of tax liabilities |  | 454,320 |  | 697,964 | 120,739 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share price (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 25.42 |  |  |  | $ 19.53 | $ 22.37
Restricted Shares | Management Award 2016 | Ordinary shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of equity instruments exercised (in shares) |  | 587,633 |  | 928,042 | 163,816 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Restricted Shares | Management Award 2018 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of equity instruments exercised (in shares) |  |  | 42,825 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Reclassification of awards for settlement of tax liabilities |  |  | 17,170 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Share price (in Dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 25.30 |  |  |
Restricted Shares | Management Award 2018 | Ordinary shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of equity instruments exercised (in shares) |  |  | 25,655 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
January 1, 2016 | Restricted Shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of equity instruments outstanding in share-based payment arrangement (in shares) |  |  |  |  |  |  |  |  |  |  | 0 |  |  |  | 1,041,953 |  |  |  |
New awards granted in the period |  |  |  |  |  |  |  | 0 |  |  |  |  |  |  |  |  |  |  |
Number of equity instruments exercised (in shares) |  |  |  |  |  |  |  | 1,041,953 |  |  |  |  |  |  |  |  |  |  |
January 1, 2017 | Restricted Shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of equity instruments outstanding in share-based payment arrangement (in shares) |  |  |  |  |  |  |  |  |  |  | 0 |  |  |  | 819,873 |  |  |  |
New awards granted in the period |  |  |  |  |  |  |  | 0 |  |  |  |  |  |  |  |  |  |  |
Number of equity instruments exercised (in shares) |  |  |  |  |  |  |  | 819,873 |  |  |  |  |  |  |  |  |  |  |
January 1, 2019 | Restricted Shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of equity instruments outstanding in share-based payment arrangement (in shares) |  |  |  |  |  |  |  |  |  |  | 152,695 |  |  |  | 159,561 |  |  |  |
New awards granted in the period |  |  |  |  |  | 166,427 |  | 0 |  |  |  |  |  |  |  |  |  |  |
Number of equity instruments exercised (in shares) |  |  |  |  |  |  |  | 0 |  |  |  |  |  |  |  |  |  |  |
January 1, 2020 | Restricted Shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Disclosure of number and weighted average remaining contractual life of outstanding share options [line items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Number of equity instruments outstanding in share-based payment arrangement (in shares) |  |  |  |  |  |  |  |  |  |  | 645,093 |  |  |  | 710,438 |  |  |  |
New awards granted in the period |  |  |  |  | 761,979 |  |  | 0 |  |  |  |  |  |  |  |  |  |  |
Number of equity instruments exercised (in shares) |  |  |  |  |  |  |  | 0 |  |  |  |  |  |  |  |  |  |  |

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageRemainingContractualLifeOfOutstandingShareOptionsLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2021-01-01 -Paragraph 112 -Subparagraph c -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_112_c&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 47 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard -URIDate 2021-03-24 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 45 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) exercised or vested in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 45 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) outstanding in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 45 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_NumberOfOtherEquityInstrumentsOutstandingInSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | instant

X
- Definition Liabilities From Share-based Payment Transactions, Shares + References No definition available. + Details
Name: | nomd_LiabilitiesFromSharebasedPaymentTransactionsShares
Namespace Prefix: | nomd_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period + References No definition available. + Details
Name: | nomd_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingPeriod2
Namespace Prefix: | nomd_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Shares Issued, Price Per Share1 + References No definition available. + Details
Name: | nomd_SharesIssuedPricePerShare1
Namespace Prefix: | nomd_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | ifrs-full_PerformanceObligationsAxis=nomd_EarningsBeforeInterestTaxDepreciationAndAmortisationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_PerformanceObligationsAxis=nomd_SharePricePerformanceMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_PerformanceObligationsAxis=nomd_CumulativeNetSalesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=nomd_ManagementAward2018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=nomd_RestrictedStock1Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_TitleOfIndividualAxis=ifrs-full_KeyManagementPersonnelOfEntityOrParentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=nomd_ManagementAward2017Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_CategoriesOfRelatedPartiesAxis=nomd_ManagementAward2016Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | nomd_AwardDate1Axis=nomd_January12016Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | nomd_AwardDate1Axis=nomd_January12017Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | nomd_AwardDate1Axis=nomd_January12019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | nomd_AwardDate1Axis=nomd_January12020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |